Literature DB >> 12374850

Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

Timothy D Warner1, Jane A Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12374850      PMCID： PMC129677          DOI： 10.1073/pnas.222543099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  37 in total

Review 1.  Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy.

Authors:  J A Mitchell; T D Warner
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 2.  Paracetamol: past, present, and future.

Authors:  L F Prescott
Journal:  Am J Ther       Date:  2000-03       Impact factor: 2.688

Review 3.  Paracetamol-inhibitable COX-2.

Authors:  R Botting
Journal:  J Physiol Pharmacol       Date:  2000-12       Impact factor: 3.011

Review 4.  The fight against rheumatism: from willow bark to COX-1 sparing drugs.

Authors:  J R Vane
Journal:  J Physiol Pharmacol       Date:  2000-12       Impact factor: 3.011

5.  Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity.

Authors:  T A Samad; K A Moore; A Sapirstein; S Billet; A Allchorne; S Poole; J V Bonventre; C J Woolf
Journal:  Nature       Date:  2001-03-22       Impact factor: 49.962

Review 6.  Antipyretics: mechanisms of action and clinical use in fever suppression.

Authors:  D M Aronoff; E G Neilson
Journal:  Am J Med       Date:  2001-09       Impact factor: 4.965

7.  Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.

Authors:  M Dougados; J M Béhier; I Jolchine; A Calin; D van der Heijde; I Olivieri; H Zeidler; H Herman
Journal:  Arthritis Rheum       Date:  2001-01

8.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

Authors:  T D Warner; F Giuliano; I Vojnovic; A Bukasa; J A Mitchell; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

Authors:  D Riendeau; M D Percival; C Brideau; S Charleson; D Dubé; D Ethier; J P Falgueyret; R W Friesen; R Gordon; G Greig; J Guay; J Mancini; M Ouellet; E Wong; L Xu; S Boyce; D Visco; Y Girard; P Prasit; R Zamboni; I W Rodger; M Gresser; A W Ford-Hutchinson; R N Young; C C Chan
Journal:  J Pharmacol Exp Ther       Date:  2001-02       Impact factor: 4.030

Review 10.  Aspirin: new cardiovascular uses for an old drug.

Authors:  C Patrono
Journal:  Am J Med       Date:  2001-01-08       Impact factor: 4.965
View more
  46 in total

1.  Nonsteroidal antiinflammatory drugs inhibiting prostanoid efflux: as easy as ABC?

Authors:  Timothy D Warner; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

Review 2.  What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine.

Authors:  A Scott; K M Khan; C R Roberts; J L Cook; V Duronio
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

Review 3.  Recent methodologies toward the synthesis of valdecoxib: a potential 3,4-diarylisoxazolyl COX-II inhibitor.

Authors:  Sureshbabu Dadiboyena; Adel Nefzi
Journal:  Eur J Med Chem       Date:  2010-08-06       Impact factor: 6.514

4.  Investigation of the Interaction Between Human Serum Albumin and Two Drugs as Binary and Ternary Systems.

Authors:  Nooshin Abdollahpour; Vahid Soheili; Mohammad Reza Saberi; Jamshidkhan Chamani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

5.  Inhibition of Radiation-Induced Oxidative Damage in the Lung Tissue: May Acetylsalicylic Acid Have a Positive Role?

Authors:  Can Demirel; Sevil Cagiran Kilciksiz; Serkan Gurgul; Nurten Erdal; Seyran Yigit; Lulufer Tamer; Lokman Ayaz
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

6.  A computational protocol for the integration of the monotopic protein prostaglandin H2 synthase into a phospholipid bilayer.

Authors:  Philip W Fowler; Peter V Coveney
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

7.  Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.

Authors:  Hikmet Akkız; Süleyman Bayram; Aynur Bekar; Ersin Akgöllü; Yakup Ülger
Journal:  Mol Cell Biochem       Date:  2010-11-02       Impact factor: 3.396

8.  Clopidogrel enhances periodontal repair in rats through decreased inflammation.

Authors:  Leila S Coimbra; Joao Paulo Steffens; Carlos Rossa; Dana T Graves; Luis C Spolidorio
Journal:  J Clin Periodontol       Date:  2014-01-16       Impact factor: 8.728

9.  The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs.

Authors:  Glen Reid; Peter Wielinga; Noam Zelcer; Ingrid van der Heijden; Annemieke Kuil; Marcel de Haas; Jan Wijnholds; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

10.  Ecotoxicological effects of salicylic acid in the freshwater fish Salmo trutta fario: antioxidant mechanisms and histological alterations.

Authors:  B Nunes; J C Campos; R Gomes; M R Braga; A S Ramos; S C Antunes; A T Correia
Journal:  Environ Sci Pollut Res Int       Date:  2014-08-07       Impact factor: 4.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.